CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • Publications
  • Job Openings
  • Products and Services
  • Learning Box
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Rodrigo Ortiz

  • Articles
  • Clinicians
  • Pacients
  • Cell therapy
  • Gen Therapy
  • Laboratory
  • Pre Clinical
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
7 January 2025

Combining cytokines and pyroptosis, a promising weapon against cancer

A recent study published in Nature Communications has unveiled a groundbreaking approach that combines the power of cytokines with a type of cell death called pyroptosis to boost the immune system's ability to fight ...

Cytokine Pyroptosis
  • Latest
  • Media Releases
  • Clinicians
  • Pacients
  • Researchers
  • Research
  • CTGCT
  • Rodrigo Ortiz
  • Rodrigo Ortiz
11 December 2024

CTGCT Newsletter, 1st year in review

Welcome to the first CTGCT Newsletter featuring a selection of the articles we're most proud of in the last year.

  • Articles
  • Media Releases
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Research
  • Charite Berlin
  • CTGCT
  • NIC
  • TUD
  • UCL
  • UMCUtrecht
  • Rodrigo Ortiz
6 December 2024

CTGCT’s Innovation Report on Gene and Cell Therapy

We are pleased to share that our latest paper has been accepted for publication in the Computational and Structural Biotechnology Journal (CSBJ)

Innovation Report Abstract
  • Articles
  • Pacients
  • Gen Therapy
  • Drug Discovery
  • Laboratory
  • Research
  • CTGCT
  • NIC
  • Rodrigo Ortiz
22 November 2024

MyD88 balances cell homeostasis by regulating immune response, mitochondrial function and cell death

A recent study by researchers in the CTGCT investigates the role of the MyD88 protein, a key player in innate immune signaling pathways.

Myd88 Blogpost Cover
  • Articles
  • Clinicians
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • GLP
  • GMP
  • Manufacturing Process
  • Pre Clinical
  • Regulation
  • UCL
  • Rodrigo Ortiz
4 November 2024

Transforming Advanced Therapy Manufacturing: The Braintree Innovation Centre

case study on the Braintree Manufacturing Innovation Centre (Braintree MIC), recently licensed by the MHRA. This state-of-the-art facility is revolutionizing the field of advanced therapy medicinal products (ATMPs) by providing cutting-edge infrastructure and expertise ...

Braintree Mic
  • Events
  • Researchers
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Economics
  • CTGCT
  • NIC
  • Rodrigo Ortiz
23 October 2024 Event Date: 9 October 2024 • 09:00 do: 11 October 2024 • 16:00

3rd Teaming Club Conference – Novi Sad

The CTGCT presented the project in the 3rd Teaming Club Conference in Novi Sad, Serbia.

1728588285187 (1)
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Regulation
  • CTGCT
  • NIC
  • Rodrigo Ortiz
20 September 2024

Bridging Gaps: ERN ITHACA and SATB2 Europe Visit the Center for Technologies of Gene and Cell Therapy

The CTGCT hosted representatives from ERN ITHACA and SATB2 Europe to discuss collaborative efforts in rare disease research and treatment. The meeting focused on developing innovative therapies and strengthening connections between researchers, clinicians, and ...

Ern Ithaca Visit

Posts pagination

1 2

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ministry Logo

 

Project: 101059842 – CTGCT – HORIZON-WIDERA-2022

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them


CTGCT © 2025
Website production: Kreativna tovarna